ELISpot and FluoroSpot Assay Market Size, Share & Trends Analysis Report By Product (Assay Kits, Analyzers, Ancillary products), By Application (Diagnostic Applications, Research Applications), By End-User, By Region, And By Segment Forecasts, 2023-2031

Report ID : 2000 | Published : 2023-08-26 | Pages: 180 | Format: PDF/EXCEL

The ELISpot and FluoroSpot Assay Market Size is valued at USD 276.18 Mn in 2022 and is predicted to reach USD 512.39 Mn by the year 2031 at a 7.2 % CAGR during the forecast period for 2023-2031.

ELISpot and FluoroSpot Assay Market

Several reasons are predicted to drive the ELISpot and FluoroSpot assay market. For starters, expanding vaccine research to combat drug-resistant strains, the increasing global prevalence of chronic illnesses, and technological advancements in ELISpot and FluoroSpot analyzers and test kits are likely to drive market expansion. ELISpot is an important technique in producing vaccines for various disorders, including AIDS, tuberculosis, malaria, cancer, and influenza. The ELISpot test is commonly used in clinical research to evaluate vaccinations. According to a June 2021 article published in BMC Infectious Diseases Journal, the FluoroSpot assay based on the ELISpot was more accurate than enzyme-linked immunoassay (ELISA) or flow cytometry (FCM). As a result, these assays are given priority to ensure precision in research diagnosis.

Key companies' strategic activities, such as product launches, approvals, alliances, and research projects, are also projected to drive market expansion. Ardigen and ImmuMap, for example, announced a research agreement in April 2021 aimed at discovering T-cell receptors (TCRs) receptive to tumor-associated neoantigens. The cooperation includes ELISpot tests, next-generation sequencing (NGS), MHC multimer labelling and sorting, and 10x Genomics Single Cell Immune Profiling. Such advancements are projected to stimulate assay innovation and, as a result, market growth. 

Competitive Landscape:

Some major key players in the ELISpot and FluoroSpot Assay Market:

  • Oxford Immunotec (UK)
  • Cellular Technology Limited (US)
  • Mabtech (Sweden)
  • Becton Dickinson and Company (US)
  • Abcam plc. (UK) 
  • Bio-Techne. (US)
  • Mikrogen Diagnostik (Germany)
  • Autoimmun Diagnostika GmbH (Germany)
  • U-CyTech (Netherlands)
  • Medix Biochemica (Finland)
  • Merck KGaA (Germany)
  • Bio-Sys GmbH (Germany)
  • Anogen-Yes Biotech Laboratories Ltd (Canada)
  • Abnova Corporation (Taiwan)
  • Biorbyt Ltd (UK),
  • Tokyo Chemical Industry Co., Ltd. (Japan),
  • MP BIOMEDICALS. (US),
  • BOC Sciences. (US),
  • ZenBio, Inc (US)
  • Jackson ImmunoResearch Inc (US),
  • Krishgen Biosystems. (India)
  • NATIONAL ANALYTICAL CORPORATION (India),
  • STEMCELL Technologies Inc. (Canada),
  • SERVA Electrophoresis GmbH (Germany),
  • IST Scitific LTD (England). 

Market Segmentation: 

The ELISpot and FluoroSpot Assay market is segmented based on product, application, and end-user. The market is segmented as assay kits by technique, by utility, by analyte, analyzers, and ancillary products based on product. The application segment includes diagnostic applications and research applications. Based on end-user, the market is bifurcated into hospitals & clinical labs, research institutes, and biopharmaceutical companies & CROs. 

Based On Product, The Assays & Kits Segment Is Accounted As A Major Contributor In The ELISpot And FluoroSpot Assay Market 

Assay kits are essential in a variety of applications, such as life science research, medicine development, and environmental monitoring. These applications include disease pathway research, screening for potential medication candidates, and evaluating biopharmaceutical manufacturing processes. Because of reasons such as the high prevalence of chronic diseases and the increased usage of these goods for vaccine development in clinical research, the assay kits segment maintains a dominant share. 

The Research Institutes Segment Witnessed Growth At A Rapid Rate 

The research institutes segment is expected to expand moderately over the projection period. The segment's expansion can be attributed to a greater emphasis on R&D activities in research institutes, particularly in the domains of immunology, infectious illnesses, and cancer research. More research institutes are expected to adopt ELISpot and Fluorospot assays for research and development purposes, propelling market growth in this sector. 

In The Region, The North American ELISpot and FluoroSpot Assay Market Holds A Significant Revenue Share 

Due to the presence of FDA-approved ELISpot and FluoroSpot test kits, the presence of health remuneration policies, the rise in chronic infection, and the rise in the older population, the United States dominates the global ELISpot and FluoroSpot assay in the North America region. The test kits segment is dominant in the United States because it is cost-effective and offers accurate therapy for patients in the United States. Germany, on the other hand, dominates the global ELISpot and FluoroSpot assay in the European area due to the presence of untapped prospects for ELISpot and FluoroSpot assay in Germany and the increased prevalence of cancer patients in Germany.  

ELISpot and FluoroSpot Assay Market Report Scope:

Report Attribute

Specifications

Market Size Value In 2022

USD 276.18 Mn

Revenue Forecast In 2031

USD 512.39 Mn

Growth Rate CAGR

CAGR of 7.2 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, Application, End-User

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Oxford Immunotec (UK), Cellular Technology Limited (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam plc. (UK), Bio-Techne.(US), Mikrogen Diagnostik (Germany), Autoimmun Diagnostika GmbH (Germany), U-CyTech (Netherland), Medix Biochemica (Finland), Merck KGaA (Germany), Bio-Sys GmbH (Germany), Anogen-Yes Biotech Laboratories Ltd (Canada), Abnova Corporation. (Taiwan), Biorbyt Ltd (UK), Tokyo Chemical Industry Co., Ltd. (Japan), MP BIOMEDICALS. (US), BOC Sciences. (US), ZenBio, Inc (US), Jackson ImmunoResearch Inc (US), Krishgen Biosystems. (India), NATIONAL ANALYTICAL CORPORATION (India), STEMCELL Technologies Inc. (Canada), SERVA Electrophoresis GmbH (Germany), IST Scitific LTD (England).

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Segmentation of ELISpot and FluoroSpot Assay Market-

ELISpot and FluoroSpot Assay Market By Product-

  • Assay Kits
    • Assay Kits by Technique
      • ELISpot Assay Kits
      • FluroSpot Assay Kits
    • Assay Kits by Utility
      • Diagnostic Kits
      • Research Kits
    • Assay Kits by Analyte
      • T-cell-based kits
      • B-cell-based kits
      • Other analytic kits
    • Analyzers
    • Ancillary products

ELISpot and FluoroSpot Assay Market

ELISpot and FluoroSpot Assay Market By Application-

  • Diagnostic Applications
    • Infectious Diseases
    • Transplants
  • Research Applications
    • Vaccine Development
    • Clinical Trials
    • Cancer Research

ELISpot and FluoroSpot Assay Market By End-User-

  • Hospitals & Clinical Labs
  • Research Institutes
  • Biopharmaceutical Companies and CROs

ELISpot and FluoroSpot Assay Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the ELISpot and FluoroSpot Assay Market?

ELISpot and FluoroSpot Assay Market expected to grow at a 7.2 % CAGR during the forecast period for 2023-2031

Oxford Immunotec (UK), Cellular Technology Limited (US), Mabtech (Sweden), Becton, Dickinson and Company (US), Abcam plc. (UK), Bio-Techne.(US), Mikro

Our Clients

Media Citations

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get a Custom Report
Contact us with a specific research request.

Kindly share us with a topic or product segment or objectives to meet your strategy goals

Review Request

We’ll review your request & send a personalized quote for cost and time needed

Final Delivery

Sit back while our team work on your research. We will send bi-monthly updates and discuss our finding on a conference call upon final delivery..